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Abstract 2
The epigenome has been shown to deteriorate with age, potentially impacting on ageing-related disease. tRNA, 3
while arising from only ˜46kb (<0.002% genome), is the second most abundant cellular transcript. tRNAs also 4
control metabolic processes known to affect ageing, through core translational and additional regulatory roles. 5
Here, we interrogate the DNA methylation state of the genomic loci of human tRNA. We identify a genomic 6
enrichment for age-related DNA hypermethylation at tRNA loci. Analysis in 4,350 MeDIP-seq peripheral-blood 7
DNA methylomes (16-82 years), identifies 44 and 21 hypermethylating specific tRNAs at study-and genome-wide 8
significance, respectively, contrasting with 0 hypomethylating. Validation and replication (450k array & 9
independent targeted Bisuphite-sequencing) supported the hypermethylation of this functional unit. 10
Tissue-specificity is a significant driver, although the strongest consistent signals, also independent of major 11
cell-type change, occur in tRNA-iMet-CAT-1-4 and tRNA-Ser-AGA-2-6. This study presents a comprehensive 12
evaluation of the genomic DNA methylation state of human tRNA genes and reveals a discreet hypermethylation 13
with advancing age. 14
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Introduction 15
Ageing is implicated as a risk factor in multiple chronic diseases [1]. Understanding how the ageing process leads 16
to deteriorating biological function is now a major research focus, with hopes to increase the human ‘healthspan’ 17
and ameliorate the extensive physical, social and economic costs of these ageing-related disorders [2]. Epigenetic 18
processes, which influence or can inform us about cell-type specific gene expression, are altered with age and are, 19
furthermore, one of the fundamental hallmarks of this progression [3,4]. 20
DNA methylation (DNAm) is the most common epigenetic modification of DNA and age-associated changes 21
in this mark in mammalian tissues have been recognised for decades [5]. In fact, these alterations in DNAm with 22
age are extensive with thousands of loci across the genome affected. Many represent ‘drift’ arising from the 23
imperfect maintenance of the epigenetic state [6]. However, specific genomic regions show distinct directional 24
changes, with loss of DNA methylation in repetitive or transposable elements [7], as well as gains in certain 25
promoters, including the targets of polycomb repressor complex [8] and bivalent domains [9]. These observations 26
with the advent of high-throughput DNAm arrays also permitted the identification of individual CpG sites that 27
exhibit consistent changes with age, enabling the construction of predictors of chronological age known as 28
epigenetic or DNAm ‘clocks’ [10–13]. Additionally, it was observed that ‘acceleration’ of this DNAm-derived 29
measure is a biomarker of ‘biological’ ageing due to associations with morbidity and mortality (Reviewed in [14] 30
& [15]). In a previous investigation of ageing-related DNAm changes within common disease-associated GWAS 31
regions, we identified hypermethylation of the specific transfer RNA gene, tRNA-iMet-CAT-1-4 [16]. The 32
initiator methionine tRNA possesses certain unique properties, including its capacity to be rate limiting for 33
translation [17], association with the translation initiation factor eIF2 [18], and ability to impact the expression 34
of other tRNA genes [19]. 35
tRNAs are evolutionarily ancient [20] and fundamental in the translation process for all domains of life. This 36
translation machinery and the regulation of protein synthesis are controlled by conserved signalling pathways 37
shown to be modifiable in longevity and ageing interventions [21]. Additionally, beyond their core role in the 38
information flow from DNA to protein sequence, tRNAs can fragment into numerous tRNA-derived small RNAs 39
(tsRNAs) [22] with signalling and regulatory functions [23–26]. 40
When liberally considering the 610 loci annotated as tRNA genes, as well as tRNA pseudo genes, nuclear 41
encoded mitochondrial tRNA genes and possibly some closely related repetitive sequences, these features 42
(gtRNAdb [27]) cover <46 kb (including introns) which represents <0.002% of the human genome [28]. Yet a 43
subset of these genes produce the second most abundant RNA species next to ribosomal RNA [29] and are 44
required for the production of all proteins. tRNA genes are transcribed by RNA polymerase III (polIII) [30] and 45
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have internal type II polIII promoters [31]. DNAm is able to repress the expression of tRNA genes 46
experimentally [32] but may also represent co-ordination with the local repressive chromatin state [33]. 47
Transcription is also repressed by the highly conserved polIII specific transcription factor Maf1 [34,35], who’s 48
activity is modulated by the Target of Rapamycin Kinase Complex 1 (TORC1) [36]. TORC1 is a highly 49
conserved hub for signals that modulate ageing [37]. 50
tRNAs as well as tsRNAs are integral to the regulation of protein synthesis and stress response, two processes 51
known to be major modulators of ageing. Metabolic processes are also recognised to modulate the age estimates 52
of DNAm clocks [38]. Partial inhibition of translation increases lifespan in multiple model organisms [39] and 53
PolIII inhibition increases longevity acting downstream of TORC1 [40]. Furthermore, certain tsRNAs circulating 54
in serum can be modulated by ageing and caloric restriction [41]. 55
We directly investigated ageing-related changes in the epigenetic DNA methylation state of the entire tRNA 56
gene set, facilitated by the availability of a large-scale MeDIP-seq dataset. Arrays poorly cover this portion of 57
genome, with even the latest EPIC (850k) arrays only covering <15% of the tRNA genes, with robust probes, and 58
in total only ˜4.7% of all the tRNA gene CpGs [42]. tRNA genes sit at the heart not only of the core biological 59
process of translation but at a nexus of signalling networks operating in several different paradigms, from small 60
RNA signalling to large scale chromatin organisation [43]. In summary, tRNA biology, protein synthesis, nutrient 61
sensing, stress response and ageing are all intimately interlinked. In this study, we have identified tRNA gene 62
DNA hypermethylation and independently replicated this newly described ageing-related observation. 63
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Results 64
DNA Methylation of Specific tRNA Gene Loci Changes with Age 65
Due to tRNAs critical role in translation and evidence of their modulation in ageing and longevity-related 66
pathways, we interrogated these genes for evidence of ageing-related epigenetic changes. Our discovery set was a 67
large-scale peripheral blood-derived DNA methylome dataset comprising of 4350 samples. This sequencing-based 68
dataset had been generated by Methylated DNA Immunoprecipitation (MeDIP-seq) [44], which relies on the 69
enrichment of methylated fragments of 200-500 bp to give a regional DNAm assessment (500 bp semi-overlapping 70
windows, see Methods). There are 416 high confidence tRNA genes in the human genome, we initially examined 71
an expanded set of 610 tRNA-like features identified by tRNAscan including pseudogenes, possible repetitive 72
elements, and nuclear encoded mitochondrial tRNAs [27,45]. Of these 492 were autosomal and did not reside in 73
blacklisted regions of the genome [46]. Due to the small size of these tRNAs (60-86bp, median 73bp, excluding 74
introns which are present in ˜30 tRNAs with sizes from 10-99bp, median 19bp), this fragment-based method 75
enabled a robust examination of the epigenetic state of these highly similar sequences. This was supported by a 76
mappability assessment. The median mappability score density for all tRNA genes was 0.90 for 50mers when 77
considering tRNA genes ±500bp reflecting the regional nature of the MeDIP-seq assay. In contrast the 50mer 78
mappability density is 0.68 for tRNA genes alone, which would be representative of the mappability of reads 79
generated using a technique such as whole-genome bisulfite sequencing (see Figures Supplementary Figure 1 & 80
Supplementary Figure 2). 81
We identified 21 genome-wide significant and 44 study-wide significant results (p < 4.34× 10−9 and 82
8.36× 10−5, respectively), via linear regression (n=4350, see Methods). Study-wide significance was calculated 83
conservatively with the Bonferroni method for all 598 autosomal tRNAs and closely related features. There was a 84
strong directional trend with all results at both significance levels being due to increases in DNA methylation. 85
Age-related changes in cell type proportion are strong in heterogeneous peripheral blood, and include a myeloid 86
skew, loss of naive T cells and increases in senescent cells [47]. A subset of 3 genome-wide and 16 study-wide 87
significant hypermethylation results remained significant even after correcting for potential cell-type changes by 88
including lymphocytes, monocytes, neutrophils and eosinophil cell count data (n=3001, Listed in Figure 1, see 89
Figure Supplementary Figure 3). Going forward we refer to these cell-type corrected sets of 3 and 16 tRNA genes 90
as the genome-wide and study-wide significant tRNA genes respectively. 91
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MeDIP 450k Array Targeted BiS-seq
tRNA Window Slope p-value Slope p-value Slope p-value
tRNA-Gln-CTG-7-1 Chr1:147,800,750-147,801,250 0.84 2.60e-05 NA NA NA NA
Chr2:131,094,500-131,095,000 1.11 4.64e-09 NA NA NA NA
Chr2:131,094,250-131,094,750 1.00 1.12e-07 NA NA NA NAtRNA-Glu-TTC-1-1
Chr2:131,094,750-131,095,250 1.00 3.28e-07 NA NA NA NA
tRNA-His-GTG-1-2 Chr1:146,544,500-146,545,000 0.92 1.38e-06 NA NA NA NA
Chr1:149,155,750-149,156,250 1.05 2.98e-08 NA NA NA NAtRNA-His-GTG-2-1 Chr1:149,155,500-149,156,000 0.83 1.37e-05 NA NA NA NA
Chr6: 27,251,500- 27,252,000 1.07 1.45e-08 NA NA 1.30 1.22e-03tRNA-Ile-AAT-10-1 Chr6: 27,251,750- 27,252,250 0.90 1.86e-06 NA NA 1.30 1.22e-03
Chr17: 8,130,000- 8,130,500 1.19 2.98e-10 0.20 8.92e-06 -0.74 6.88e-04tRNA-Ile-AAT-4-1 Chr17: 8,130,250- 8,130,750 0.77 3.99e-05 0.20 8.92e-06 -0.74 6.88e-04
tRNA-Ile-TAT-2-2 Chr6: 26,987,750- 26,988,250 0.97 7.25e-07 0.04 1.17e-02 -0.60 3.84e-01
Chr6: 26,330,500- 26,331,000 1.28 2.83e-11 0.13 6.07e-06 4.54 9.35e-04tRNA-iMet-CAT-1-4 Chr6: 26,330,250- 26,330,750 1.13 2.89e-09 0.13 6.07e-06 4.54 9.35e-04
Chr14: 21,093,250- 21,093,750 1.04 9.38e-08 NA NA 2.49 8.77e-03tRNA-Leu-TAG-2-1 Chr14: 21,093,500- 21,094,000 0.94 8.50e-07 NA NA 2.49 8.77e-03
Chr6: 26,555,500- 26,556,000 1.04 3.97e-08 NA NA NA NAtRNA-Pro-AGG-2-2 Chr6: 26,555,250- 26,555,750 1.01 9.58e-08 NA NA NA NA
tRNA-Ser-ACT-1-1 Chr6: 27,261,250- 27,261,750 0.97 3.53e-07 NA NA 0.66 1.45e-01
Chr17: 8,129,750- 8,130,250 1.21 1.16e-10 0.21 6.72e-05 0.62 4.28e-02tRNA-Ser-AGA-2-6 Chr17: 8,130,000- 8,130,500 1.19 3.03e-10 0.21 6.72e-05 0.62 4.28e-02
tRNA-Ser-TGA-2-1 Chr6: 27,513,000- 27,513,500 0.90 3.58e-06 0.87 1.38e-04 -0.25 5.74e-01
tRNA-Val-AAC-1-2 Chr5:180,590,750-180,591,250 0.91 3.28e-06 NA NA NA NA
Chr6: 27,648,500- 27,649,000 1.07 1.25e-08 0.40 9.90e-03 NA NAtRNA-Val-AAC-4-1 Chr6: 27,648,750- 27,649,250 0.95 4.31e-07 0.40 9.90e-03 NA NA
tRNA-Val-CAC-2-1 Chr6: 27,247,750- 27,248,250 0.85 2.33e-05 0.59 5.05e-06 NA NA
Figure 1. Ageing-related DNA methylation changes in tRNA loci (16 Study-wide significant after
blood cell-type correction, p < 8.36× 10−5). Columns left to right: tRNA gene; Genomic location of MeDIP-seq
significant window (hg19); MeDIP results slope (arbitrary units) and p-value; 450k Array results slope (beta) and
p-value (Blood-cell corrected and combined for all probes overlapping tRNA); Targeted Bisulphite-sequencing
(BiS-seq) slope (model beta) and p value (combined all CpGs in targeted region, see Methods). Units of slope are
quantile normalised RPM values or MeDIP-seq models and proportion of CpG sites methylated for the targeted
bisulfite and array based assays, all per unit time. Result for all covered tRNAs are included in the
supplementary data (1, 3, & 4). All p-values are for F-tests from simple linear regression. For slope: Orange =
hypermethylation and Blue = hypomethylation with age. For p-values: Colour gradient high significance = dark
blue to low significance = yellow, scaled relative to column. Blank grey cells indicate unavailable data.
Due to the related nature of these twin samples, we also analysed these data in two subsets of n = 1198 & 92
1206 by selecting one twin from each pair into the separate sets. This analysis also included correction for Blood 93
Cell counts. Even in these smaller sets, 5 and 7 tRNA genes, respectively, reached study-wide significance. In 94
these sets 5/5 and 6/7 of these were present in 16 study-wide significant tRNA genes. 95
Furthermore, we examined a subset of samples with longitudinal data (n=658 methylomes from 329 96
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individuals, median age difference 7.6 yrs). At the nominal significance threshold (p < 0.05) this yielded a split 97
of 41 hypermethylating tRNA genes and 22 hypomethylating tRNA genes. Of these hypermethylated tRNAs, 2 98
are in the previously identified genome-wide significant set of 3 (with tRNA-iMet-CAT-1-4 ranked 3rd by p-value) 99
and 9 are in the study-wide significant set of 16. We also ran a number of additional analyses to investigate this 100
directional observation further, including performed linear mixed modeling with batch, lymphocyte, monocyte, 101
neutrophil and eosinophil cell count data, as fixed effects, and family id and zygosity as random effects. Thus we 102
have observed the same consistent hypermethylation trend with age across a wide array of models, with and 103
without correction for cell-type composition, and when either correcting for structure in our sample population or 104
when examining those sub-populations separately. Full results for each age model are provided in Supplementary 105
Data 1 106
tRNA Genes are Enriched for Age Related DNA Hypermethylation 107
Whilst ageing changes are pervasive throughout the DNA methylome, we identified a strong enrichment for this 108
to occur within the tRNA genes (Fisher’s Exact Test p = 1.05× 10−27) (see Figure 2 b). This is still significant if 109
the 6 of the study-wide significant 16 tRNAs that have any overlap with polycomb or bivalent regions are 110
excluded (p = 4.66× 10−15) 111
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Figure 2. Age-related hypermethylation is enriched in tRNA genes relative to genomic
background and accounting for CpG density A) tRNA genes are enriched for age-related
hypermethylation compared to the genomic background, Fisher’s Exact Test p < 1.05× 10−27, 1-sided). All
Fisher’s exact test results are included in Supplementary data 2 (CGI) CpG islands. B) tRNA genes show more
significant hypermethylated loci than CpG Density matched permutations. Each permutation represented a
random set of windows matching the CpG density of the functional unit (tRNA gene loci, bivalent domains, and
polycomb group target promoters). These are subsequently assessed for significant age-related DNAm changes,
quoted p-values are empirical p-values based on the permutation results (see Methods). The red line is the
observed number of significant loci. Source data are provided as a Source Data file.
CpG density itself is known to have a clear impact on the potential for variability of the DNA methylome as 112
well as ageing-related changes [48,49]. To assess whether this hypermethylation finding was being merely driven 113
by the inherent CpG density of the tRNA genes, we performed a CpG density matched permutation analysis 114
(1,000X, see Methods). This supported the specific nature of these age-related DNAm changes within the 115
functional tRNA genes (Empirical p-value < 1.0× 10−3, Figure 2 a). As a point of comparison for this genomic 116
functional unit, we also performed the same permutations for the known age-related changes in the promoters of 117
genes that are polycomb group targets [8] and those with a bivalent chromatin state [9]. We were able to 118
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reproduce the enrichment of the polycomb group targets and bivalent regions (Empirical p-value < 1.0× 10−3) in 119
our dataset. 120
tRNA-iMet-CAT-1-4 (Figure 3a) is located in the largest tRNA gene cluster in the human genome at 121
chr6p22.2-1. This cluster contains 157 tRNA genes spanning the 2.67Mb from tRNA-iMet-CAT-1-2 to 122
tRNA-Leu-AAG-3-1, and also hosts a histone gene microcluster. tRNA-Ile-AAT-4-1 and tRNA-Ser-AGA-2-6 are 123
neighbours and are located on chromosome 17 (Figure 3b). Notably tRNA-Ile-AAT-4-1 and tRNA-Ser-AGA-2-6 124
have a third close neighbour tRNA-Thr-AGT-1-2 which does not show significant age-related hypermethylation. 125
We observe a similar pattern of sharp peaks of significance closely localised around the other loci in the 126
study-wide significant set. GENCODE 19 places tRNA-Ile-AAT-4-1 in the 3’UTR of a Nonsense-mediated decay 127
transcript of CTC1 (CST Telomere Replication Complex Component 1, CTC1-201, ENST00000449476.7) and 128
not of its primary transcript. 129
Figure 3. Age-related tRNA gene DNA hypermethylation is localised to individual tRNA genes.
MeDIP-seq results (blood cell-type corrected model) for A) tRNA-iMet-CAT-1-4 as well as B)
tRNA-Ser-AGA-2-6 and tRNA-Ile-AAT-4-1 exhibiting ageing-related DNA hypermethylation. Top to Bottom:
Chromosome ideogram; Gene locations (GENCODE 19); MeDIP-seq DNA methylation ageing −log10 p-value
results (shown for each 500 bp overlapping window); MeDIP-seq slope of change with age; MeDIP-seq Medium
coverage (Reads per Millions, RPM) calculated across all samples; CpG density (%); CpG locations (red lines);
500bp overlapping windows. The sharp peaks suggest that the results are localised to individual tRNA genes not
the entire genic locus. One window overlapping tRNA-Ile-AAT-4-1 also partially overlaps tRNA-Ser-AGA-2-6.
The 3’ UTR of the CTC1 transcript CTC1-201 (ENST00000449476.7, GENCODE 19), which is subject to
nonsense mediate decay, overlaps tRNA-Ile-AAT-4-1. tRNA genes with similar CpG density are exhibiting
differing age-related DNAm change patterns. Source data are provided as a Source Data file.
To place these hypermethylating tRNA genes in their genomic context we examined how the extended set of 130
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44 non-blood cell-type corrected study-wide significant tRNAs clustered with other tRNA genes. We clustered 131
the tRNA genes by grouping together all tRNAs within 5Mb of one another and then required that a cluster 132
contain at least 5 tRNA genes with a density of at least 5 tRNA genes per Mb (see Methods). This yielded 12 133
major tRNA gene clusters containing a total of 353 tRNA genes, 42 of the 44 study-wide significant tRNA genes 134
within these clusters (Figure 4a). The hypermethylating tRNA genes are spread evenly among these clusters 135
proportionately to their size (% ageing tRNA per cluster; non-significant one-way ANOVA). 136
Figure 4. Age-hypermethylating tRNAs Can be Seen When Comparing a Neonate to a
Centenarian and are Distributed Proportionately Across Major tRNA Gene Clusters A) No
significant clusters of ageing-related tRNA. Proportion of non-blood cell corrected ageing-related study-wide
significant tRNAs (42/44, red) within tRNA clusters (tRNAs within 5Mb with >5 tRNA genes/Mb, see Methods).
B) Covered study-wide significant tRNA genes (n = 14/16) are more methylated in a centenarian than in a
neonate or an adult (26 year) in Whole Genome Bisulfite Sequencing (WGBS) data from Heyn et al. [50]. Each
point represents individual CpG methylation levels within a tRNA gene. The horizontal lines in the violin plots
represent the 25%, 50% and 75% quantiles. (NS) Not Significant. Source data are provided as a Source Data file.
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Age-related tRNA gene set DNA Hypermethylation is even observed in one Newborn versus 137
one Centenarian 138
We examined an available Whole Genome Bisulphite sequencing (WGBS) dataset from Heyn et al. [50] (see 139
Methods) These data consisted of blood-derived DNA WGBS in one newborn child and one 26 year old, and 140
centenarian (103 years). In their analysis, the centenarian was found to have more hypomethylated CpGs than 141
the neonate across all genomic compartments, including promoters, exonic, intronic, and intergenic regions. 142
However, even in this examination of 3 individuals of 3 different ages in the 55% of tRNA genes that possessed 143
coverage, we observed DNA hypermethylation with age among the study-wide significant hypermethylating 144
tRNA genes. The centenarian was significantly more methylated in this set of tRNAs than the neonate 145
(Wilcoxon rank sum test, 6.14% increase (95% CI -Inf - 4.31), W = 717, p = 6.14× 10−4, see Figure 4b). 146
Age-related Changes Independently Replicated with Targeted Bisulfite Sequencing 147
In order to further robustly support these-ageing related changes, we attempted to replicate these findings 148
ourselves in an independent ageing dataset. Furthermore, we employed a different technology targeted bisulfite 149
(BiS) sequencing to also further validate the MeDIP-seq-derived results. These data provide individual CpG 150
resolution to identify what may be driving the regional DNAm changes observed, and precise quantitation of the 151
magnitude of change. 152
We performed this targeted BiS-seq in blood-derived DNA from 8 pools of age-matched individuals at 4 153
time-points (˜4, ˜28, ˜63, ˜78 years) from a total of 190 individuals, as detailed in Table 1. This approach 154
permitted us to assay tRNA gene DNA methylation across a large number of individuals whilst requiring a 155
minimal amount of DNA from each (80-100ng), and costing ˜1/24th as much as performing sequencing 156
individually. A total of 79 tRNA loci generated reliable results post-QC (see Methods). These tRNAs covered a 157
total of 458 CpGs with a median of 6 CpGs per tRNA (range 1-9). Median Coverage per site across pools, 158
technical replicates and batches was 679 reads (mean 5902). 159
Firstly, we ran the 8 Pooled samples on the Illumina EPIC (850k) array to confirm that our pooling approach 160
was applicable for DNAm ageing-related evaluation (Available at: GSE166503). This showed an R2 = 0.98 161
between pool mean chronological age and Horvath clock DNAm predicted age [11](see Figure 5c). Therefore, this 162
confirmed the utility of our pooling approach. We also used these array derived data to estimate the major blood 163
cell proportions for each of these pools with the Houseman algorithm [51]. 164
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Table 1. Summary information on participants in each pool Total of 190 participants in 8 pools, at 4
time points: 4, 28, 63, & 78 years
Pool Mean Age Sex Min Age Max Age n
Pool 1 4.07 Male 3.99 4.38 20
Pool 2 4.09 Female 3.99 4.36 20
Pool 3 28.07 Female 25.87 29.80 25
Pool 4 28.23 Female 26.05 30.01 25
Pool 5 63.40 Female 62.80 63.80 25
Pool 6 63.26 Female 62.70 63.70 25
Pool 7 77.96 Female 75.50 80.50 25
Pool 8 77.22 Female 74.40 80.10 25
We noted that individual tRNA loci exhibiting age-related changes in DNAm had duplicate or isodecoder 165
(same anticodon but body sequence variation) sequences in the genome, which despite exact or near sequence 166
identity did not show similar changes. tRNA-iMet-CAT-1-4 for instance is 1 of 8 identical copies in the genome 167
and was the only locus that showed significant changes. The results of pairwise differential methylation tests 168
between age groups for the 6 top tRNAs from the MeDIP-seq models are listed in Table 2. tRNA-iMet-CAT-1-4 169
shows a pairwise increase of 3.7% from age 4 years to age 78 years. 170
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Table 2. Pairwise Differences in Methylation between Age groups by tRNA p-values are for pairwise
methylation differences using a paired student’s t-test and combined by tRNA region using a generalisation of
Fisher’s method as implemented the in RnBeads v2.0.1 R package (see Methods)[52].
tRNA num. CpGs comparison p-value delta
4 vs. 28 1.518e-01 -0.2
4 vs. 63 1.774e-01 -0.234
4 vs. 78 3.060e-01 0.0113
28 vs. 63 7.152e-01 -0.0334
28 vs. 78 1.553e-01 0.212
tRNA-Ile-AAT-4-1 8
63 vs. 78 2.057e-01 0.245
4 vs. 28 8.403e-02 0.0116
4 vs. 63 1.716e-01 0.0125
4 vs. 78 1.997e-04* 0.0368
28 vs. 63 3.943e-01 0.000869
28 vs. 78 1.724e-02* 0.0252
tRNA-iMet-CAT-1-4 5
63 vs. 78 6.224e-02 0.0243
4 vs. 28 4.222e-01 0.0573
4 vs. 63 3.968e-01 0.0274
4 vs. 78 4.651e-01 0.0423
28 vs. 63 1.095e-01 -0.0299
28 vs. 78 2.126e-01 -0.015
tRNA-Ser-AGA-2-6 9
63 vs. 78 2.201e-01 0.0149
Of the 3 top hits in MeDIP-seq, tRNA-iMet-CAT-1-4 (Figure 5a(iii)) and tRNA-Ser-AGA-2-6 (Figure 171
5a(viii)) exceeded nominal significance (p-values = 9.35× 10−4 & 4.28× 10−2 , respectively). However, 172
tRNA-Ile-AAT-4-1 (Figure 5a(xi)) showed a nominal decrease in DNAm with age. tRNA tRNA-Leu-TAG-2-1 173
from the study-wide significant set also showed nominally significant hypermethylation with age (Figure 174
5a(xviii)). Also, four of the individual CpGs in tRNA-iMet-CAT-1-4 exhibited nominally significant increases in 175
DNAm with Age (Figure 5b). 176
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Figure 5. Comparison of Age-related Hypermethylating tRNA Genes to Closely Related tRNA
Genes Using Targeted Bisulfite Sequencing (BiS-seq) A) Combined CpGs within tRNA loci results
(experiment-wide Bonferroni p = 7.14× 10−4); i-iv, Comparison of select tRNA-iMet-CAT loci:
Hypermethylation is specific to iMet-CAT-1-4 (iii) not other isodecoders (i, ii, & iv); v-viii, Comparison of select
tRNA-Ser-AGA loci: Hypermethylation is specific to Ser-AGA-2-6 A (viii) and to a lesser extent Ser-AGA-2-1
(v), whilst not other isodecoders (vi, vii); ix-xiv, Comparison of select tRNA-Ile loci: Hypermethylation is specific
to Ile-AAT-10-1 (ix), Ile-AAT-4-1 (xi) displays hypomethylation contrary to previous MeDIP findings,
Ile-TAT-2-2 & 2-3 lack hypermethylation (previously non-significant in blood-corrected MeDIP, although
significant in uncorrected), whilst no change in Ile-AAT-11-1 (x) and Ile-TAT-2-1 (xii); xv-xviii, Comparison of
select tRNA-Leu loci: Hypermethylation in Leu-AAG-3-1 (xv) consistent with 450k and Leu-TAG-2-1 (xviii)
consistent with MeDIP, whilst no change in Leu-TAA-1-1 (xvi) & Leu-TAA-3-1 (xvii). B) tRNA-iMet-CAT-1-4
Individual CpG analysis: 4 CpGs within this tRNA show consistent methylation increases (all p < 0.05). C)
Mean chronological age is tightly correlated with DNAm Horvath clock [11] predicted age for the 8 pooled
samples (see Table 1 for pool details). All p-values are for F-tests from simple linear regression, Error bands
represent the SEM. Source data for these plots are provided as a Source Data file and results for all tRNAs
covered are provided in supplementary data 3
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Select Duplicates & Isodecoders of Hypermethylating tRNA loci remain unchanged We targeted 177
a selection of these duplicate and isodecoder loci for bisulfite sequencing in order to confirm that the identified 178
DNAm changes are specific to a given locus and not general to related tRNAs. Examining the tRNA-iMet-CAT-1 179
family, only the previously identified 1-4 version confirmed significant hypermethylation (not 1-2, 1-3 or 180
1-5)(Figure 5a(i-iv)). Likewise the tRNA-Ser-AGA-2-6 version was supported compared to 2-1,2-4 and 2-5(Figure 181
5a(v-viii))). Full Age model results are available in Supplementary Data 3. 182
DNA methylation 450k Array Data Validates the MeDIP-seq Results 183
Although DNA methylation array poorly covers the tRNA gene set, we wished to attempt to see if this BiS-based 184
but differing and well-established technology was supportive at all of our DNA hypermethylation findings. 185
TwinsUK had available 450k array on 587 individuals, and this platform includes 143 probes, covering 103 186
tRNAs. All the 3 top tRNAs in the MeDIP-seq results were covered by this data set, and 7 of the 16 study-wide 187
significant set. 9 tRNAs show significant (p < 4.58× 10−4) increases in DNA methylation with age in models 188
corrected for blood cell counts including all 3 of the 3 tRNAs identified in the MeDIP-seq as genome-wide 189
significant and 5 of the 7 study-wide significant set present on the array (Figure 6). Although it should be noted 190
that 56 of these 143 probes are within the non-robust set of Zhou et al. [42], including 1 of the genome-wide, and 191
1 of the study-wide results (covering tRNA-Ile-AAT-4-1 & tRNA-Val-AAC-4-1), respectively. Full age model 192
results for all tRNA probes are provided in Supplementary Data 4. 193





































Twins UK − peripheral blood Illumina 450k array
Age−related DNA methylation change in tRNA genes
Figure 6. Age-related DNA Methylation Change in tRNA Genes A) Five of seven tRNAs study-wide
significant in MeDIP covered by the 450k array also show significant hypermethylation in this data. tRNAs are
labelled if they are significant here or were in the MeDIP-seq data (Red). Model slope: the model coefficient for
the methylation values. Unfilled circles indicate those probes with potential issues generated by Zhou et al. [42],
this includes tRNA-Ile-AAT-4-1. Significance threshold: 0.05/103 ≈ 4.58× 10−4 (the number of tRNA genes
examined). Source data are provided as a Source Data file. beta = proportion methylated
Ageing-Related tRNA Loci show increased Enhancer-Related Chromatin Signatures 194
We further explored the activity of the tRNA genes in public Chromatin segmentation data in blood (Epilogos 195
Blood & T-cells set) [53,54]. This shows proportionally more Enhancer-related (Enh, EnhBiv & EnhG) 196
chromatin states at tRNA genes hypermethylating with age than the stronger Promoter-related (TSS) in other 197
tRNAs. (Figure 7 b). Whereas these characteristics are less frequently predominant in the rest of the tRNAs 198
(Figure 7 b). Age-hypermethylating tRNA are enriched for enhancer chromatin states compared to the rest of the 199
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tRNA genes (Fisher’s Exact test p = 0.01). 200
Figure 7. tRNA gene DNA methylation in different blood cell-types A) Heatmap of Mean DNA
methylation of tRNA sorted Blood Cell Types (data from Reinus et al., probes covering 8 of the 16 study-wide
significant tRNA in 7 cell-type fractions from 6 males via GSE35069, [55,56]). This illustrates the ability of
tRNA gene methylation to separate the myeloid from the lymphoid lineage and the higher methylation in the
lymphoid lineage of the 3 cell-type corrected genome-wide significant tRNAs (iMet-CAT-1-4, etc.) B) Chromatin
Segmentation data for ‘Blood & T-cell’ from Epilogos 15 State model [53,54]. Proportion represents the frequency
of the predominant chromatin state at a given tRNA (+/- 200bp) for 14/16 study-wide significant tRNAs covered
compared to other 371 available tRNAs. The ageing-related hypermethylated tRNAs are enriched for enhancer
chromatin state (Fisher’s Exact p = 0.01). C) DNA methylation in 19 tissues from TCGA normal tissue samples
and 11 fetal tissues for iMet-CAT-1-4 and Ser-AGA-2-6. Source data are provided as a Source Data file.
Age Hypermethylating tRNAs are more methylated in Lymphoid than Myeloid cells 201
Three tRNA genes remained genome-wide significant and 16 study-wide significant following correction for major 202
cell-type fraction. This is suggestive of either cell-type independent change or, presumably less likely, a very large 203
effect in a minor cell-type fraction. tRNAs have exhibited tissue-specific expression [57–59] and blood cell-type 204
populations change with age. Specifically, there is shift to favour the production of cells in the myeloid lineage 205
[47]. These points lead us to examine tRNA gene DNAm in sorted cell populations. We used a publically 206
available 450k array dataset [55]) that has been used in the construction of cell-type specific DNAm references for 207
cell-type fraction prediction using the Houseman algorithm [51] (see Methods). This consists of data from 6 208
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individuals (aged 38± 13.6/yrs) from seven isolated cell populations (CD4+ T cells, CD8+ T cells, CD56+ NK 209
cells, CD19+ B cells, CD14+ monocytes, neutrophils, and eosinophils). We found that tRNA gene DNAm could 210
separate myeloid from lymphoid lineages (Figures 7 a & Supplementary Figure 4). 211
Of the eight study-wide significant tRNAs with array coverage, we identified that collectively these eight are 212
significantly more methylated in the lymphoid than the myeloid lineage (1.1% difference, Wilcoxon rank sum test 213
p = 1.50× 10−6 95% CI 0.7%-∞). Thus, any age related increases in myeloid cell proportion would be expected 214
to dampen rather than exaggerate the age-related hypermethylation signal that we observed. In addition 215
tRNA-Ile-AAT-4-1 and tRNA-Ser-AGA-2-6 have the highest variance in their DNAm of all 129 tRNAs covered in 216
this dataset. This could represent ageing-related changes as these samples range across almost 3 decades. 217
Another possibility may be that these loci as well as hypermethylating are also increasing their variability with 218
age in a similar fashion to those identified by Slieker et al. [60]. In that study they identified that those loci 219
accruing methylomic variability were associated with fundamental ageing mechanisms. 220
tRNA Genes also Hypermethylate with Age in Solid Tissue 221
Some tRNA gene expression has been shown to be highly tissue specific [57–59]. It follows that our observations 222
of changes in DNAm with age in blood might be specific to that tissue. We used a mix of 450k and 27k array 223
data from ‘solid tissue normal’ samples made available by TCGA (The Cancer Genome Atlas) and data from 224
foetal tissue [61,62] downloaded from GEO (see Methods). The samples from TCGA range in age from 15-90 (n 225
= 733). Only 43 tRNA genes had adequate data to compare across tissues in this dataset and 115 in the foetal 226
tissue data. 227
Only 2 of the 3 tRNA genes we identified as genome-wide significant and a further 1 of the study-wide 228
significant tRNA genes are present in the set of 45 tRNA genes in the TCGA data, thus limiting our ability to 229
draw conclusions about the tissue specificity of our results. Solid tissue samples have a strong preponderance for 230
low levels of methylation consistent with the active transcription of many tRNA genes and show slight increasing 231
methylation with age but age accounts for very little of the variance (linear regression slope estimate = 1.52; 232
R2 = 0.0002; p-value 1.34× 10−3 (Figure Supplementary Figure 5d). In a pan-tissue analysis we found that 10 233
tRNA genes showed changes in DNAm with age, 9 of which were hypermethylation (p-value < 1.1× 10−3). One 234
of these tRNA genes, tRNA-Ser-TGA-2-1 was also present in study-wide significant set of tRNA genes. Figures 235
Supplementary Figure 6 & Supplementary Figure 7 illustrate minimal tissue specific differences. Interestingly, 236
however, tRNA-iMet-CAT-1-4 and tRNA-Ser-AGA-2-6 appeared more variable in methylation state than many 237
other tRNAs in the TCGA normal tissue samples (Figure Supplementary Figure 6) and indeed have the highest 238
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variance in DNA methylation across tissues (Figure Supplementary Figure 5c). These two tRNAs do show broad 239
age-related hypermethylation across a range of tissues in a comparison between fetal to adult, with interestingly, 240
directionally consistent but higher levels for tRNA-iMet-CAT1-4 in the adrenal gland (Figure 7c). 241
Mice also show age-related tRNA gene DNA hypermethylation 242
We examined the DNA methylation of the mouse tRNA genes in using data from a reduced representation 243
bisulfite sequencing (RRBS) experiment performed by Petkovich et al. [63]. These data from 152 mice covered 51 244
tRNA genes and 385 CpGs after QC (see Methods), representing ˜11% of mouse tRNA genes. The mice ranged 245
in age from 0.67-35 months. 246
Three of the 51 tRNAs showed Bonferroni significant DNA methylation changes with age (p-value < 247
1.08× 10−4) and all were in the hypermethylation direction. These three are tRNA-Asp-GTC-1-12, 248
tRNA-Ile-AAT-1-4, tRNA-Glu-TTC-1-3 (Figure 8). Full Age model Results are available in Supplementary Data 249
5. 250















































































































Significance NS p < 0.05 p < 1.147e−04
Figure 8. DNA Methylation of CpGs in 3 tRNA Genes Which Significantly Hypermethylate
With Age in Mice Data from Petkovich et al. [63]. 6 CpGs reach bonferroni significance and 7 show nominally
significant increases. Source data are provided as a Source Data file.
In order to investigate the mouse results further we made use of data from Thornlow et al. [64], which had 251
established tRNA ortholog sets for 29 mammalian species. They identified 197 mouse tRNAs as having direct 252
human orthologs with 44 of these included in the mouse results from Petkovich et al. [63]. However, 253
unfortunately, although 2 of the top 3 tRNAs (tRNA-Ser-AGA-2-6 & tRNA-Ile-AAT-4-1) have mouse orthologs 254
(tRNA-Ser-AGA-2-2 & tRNA-Ile-AAT-1-1), they are not covered in these mouse data. Furthermore, none of the 255
tRNAs showing significant hypermethylation in mice (at nominal p<0.05) had human orthologs in our 256
MeDIP-seq study-wide significant hypermethylating set. Therefore, whilst we cannot directly compare specific 257
tRNA loci due to this lack of coverage, it is interesting that the small number of significant tRNA genes in the 258
mouse data also hypermethylate with age. 259
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Discussion 260
Our work has identified a previously unknown enrichment for age-related epigenetic changes within the tRNA 261
genes of the human genome. This observation was strongly directional with increasing DNA methylation with 262
age [65]. The MeDIP-seq dataset employed brought advantages in exploring this undefined terrain of the human 263
tRNA genes. Firstly, being genome-wide it provides much increased access, as these regions are poorly covered by 264
current arrays. Secondly, being a fragment-based regional assessment of DNA methylation, the individual but 265
highly similar small tRNA genes can be surrounded by unique sequence. 266
We determined by genome-wide permutation that this strong hypermethylation signal was specific to the 267
tRNA genes, and not merely driven by the underlying CpG density of these loci. A targeted BiS-seq experiment 268
validated the defined nature of the tRNA change in an independent dataset, with a successful pooling approach, 269
which may also be useful for other ageing-related targeted DNA methylome evaluations. Additionally, we gained 270
support for our results from limited DNA methylation array data. 271
Whilst the changes in DNA methylation we have observed are relatively small (i.e. 3.7% between 4-year to 272
78-year pools in tRNA-iMet-CAT-1-4), this is consistent with the effect size seen in the majority of positions 273
differentially methylatyed with age in many other studies [60,66], except for the noted extreme outliers, such as 274
EVOLV2 [67]. Furthermore, effect size cut-offs are observed to remove a large fraction of true age-DMPs [68]. 275
We subsequently explored further what was driving this age-related phenomenon and its possible biological 276
implications. As this result was observed in peripheral blood, we were well aware that we were examining DNA 277
derived from a heterogeneous cell type population [69]. Moreover, that there are well known age-related 278
proportional changes in peripheral blood cell composition [47]. The TwinsUK MeDIP-seq and 450k array DNA 279
methylation data included measured haematological values. Therefore, we adjusted for major cell type effects, 280
such as a myeloid skew, and distinct tRNAs were still significant. Although, a caveat to our study is that this 281
can not exclude changes in minor specific sub-cell fractions types. However, that these age-related effects were 282
strong enough to be observed in both a regional MeDIP-seq assessment and a pooled sequencing approach, 283
implies that they not extremely subtle. We examined age-related tRNA gene DNA methylation changes in the 284
limited subset of mouse tRNA genes covered in publicly available RRBS data (˜13%) and were able to identify 285
tRNAs exhibiting DNA hypermethylation with age in this set. This suggests that age-related tRNA gene 286
hypermethylation may not be unique to humans, but at least observed across mammals. 287
Due to the high number of hypermethylating tRNAs prior to cell-type correction, we were also curious whether 288
the epigenetic state of this small tRNA gene fraction of genome could capture and in fact be a defined fingerprint 289
of cell type. We found that tRNA gene DNA methylation could separate myeloid from lymphoid lineages. There 290
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was also some suggestion of more fine-grained blood cell-type signatures in tRNA DNAm, such as the separation 291
of CD19+ B cells from CD4/8+ T cells. Ageing is also known to lead to an increase in senescent cells (e.g. CD8+ 292
CD28- cells). Whether these epigenetic changes in the tRNA genes uniquely represent these cell-types will 293
require technical advances to enable future single cell DNA methylome analysis to accurately assess these regions. 294
If further supported, the epigenetic state of these tRNA loci may aid the taxonomy of cell-type definition. 295
We observed a predominantly unmethylated state across fetal (Figure Supplementary Figure 7) and adult 296
tissues (Figure Supplementary Figure 6) at tRNA gene loci, consistent with the high rate of transcription at 297
many tRNA genes. We suspect that the tRNA genes largely remain unmethylated through development and that 298
the moderate increases in DNAm that we are observing with age at these loci are being driven by changes arising 299
primarily in older individuals. Distinct biological changes have been observed recently in aged individuals [70,71]. 300
Our data are supportive of the tRNA gene set representing a distinct functional unit, which lacks the logarithm 301
change in the young observed strongly in CpGs employed in ‘clocks’ [13]. This would also be consistent with the 302
lack of significant differences in the tRNA loci detected between the neonate and the 26-year-old adult in the 303
Heyn et al. data. This low baseline DNA methylation of the tRNA genes may also explain why we predominantly 304
observe hypermethylation with age. Whether this is driven by mechanisms, such as aberrant DNA methylation 305
targeting of the tRNA loci or specific sub-celltype effects with age, will require further experimental investigation. 306
This signal within the tRNA families was observed to occur at specific Isodecoders. Isodecoders expand in 307
number with organismal complexity and the high prevalence in mammals has been suggested due to their 308
additional regulatory functionality [72,73]. They also have distinct translational efficiency [74], which can also 309
have consequences in human disease [75]. After correcting for major cell types, we identified 2 tRNA genes 310
tRNA-iMet-CAT-1-4 and tRNA-Ser-AGA-2-6 which had the most consistent hypermethylation across 3 different 311
assays. Regarding the inconsistent tRNA-Ile-AAT-4-1 result, it is covered by a MeDIP-seq 500bp window which 312
exhibited genome-wide significant hypermethylation, but also partially overlaps tRNA-Ser-AGA-2-6 (Figure 3B). 313
Whilst the 450k array probe overlapping tRNA-Ile-AAT-4-1 (cg06382303) appears to replicate this 314
hypermethylation, it is a borderline case for exclusion flagged by Zhou et al. [42] due to non-unique 30bp 3’ 315
subsequence. In the targeted Bisulfite sequencing data, tRNA-Ile-AAT-4-1 exhibited a loss of methylation. These 316
factors considered together suggest that the result for tRNA-Ile-AAT-4-1 should be regarded as inconclusive. 317
Therefore, this may suggest that the hypermethylation signal observed at this locus in the MeDIP-seq data could 318
have been ‘pulled up’ by the neighbouring tRNA-Ser-AGA-2-6 hypermethylation signal. Of the 16 study-wide 319
significant tRNA genes, only these two of these have a shared significant window, furthermore, in the expanded 320
set of 44 only tRNA-Thr-AGT-1-2 could be similarly affected. 321
Furthermore, there is great complexity to the fragmentation of tRNA [23], with physiological processes such 322
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as stress shown to induce fragment production [76]. These resultant tsRNAs can feedback on protein synthesis by 323
regulating ribosome biogenesis [77] and others have diverse regulatory functions such as targeting transposable 324
element transcripts [78]. They are also observed to circulate in the blood in a cell-free fashion, and fragment 325
levels can be modulated by ageing and calorie restriction [41]. The isodecoder specific nature of our findings 326
frame a possible hypothesis for regulatory change with age and future work will be required to unravel this 327
potential. tsRNA abundance has been associated with locus specific tRNA gene expression, in some cases 328
independent of mature tRNA levels [79]. This has important implications for the interpretation of our results 329
given the multi-copy nature of genes like tRNA-iMet-CAT-1-4, as even if expression levels of mature iMet tRNAs 330
are unaffected by changes in one copy’s DNA methylation, these changes could still influence the levels of 331
particular tsRNAs derived from specific tRNA loci. 332
The location of tRNA-Ser-AGA-2-6 and tRNA-Ile-AAT-4-1 immediately downstream of CTC1 and of 333
tRNA-Ile-AAT-4-1 within the 3’UTR of an alternate isoform of CTC1, which undergoes nonsense-mediated decay, 334
raises the possibility that the gene body epigenetic regulation of CTC1 may impact on the state of these tRNA 335
genes. CTC1 ’s function in telomere maintenance [80], DNA replication licensing [81], and it’s role in a rare 336
progeroid condition [82] indicate that it has ageing-relevant biology. The possible relationship between the 337
regulation of CTC1 and that of the tRNA genes downstream of it warrants further study. 338
Whilst, the expression of the tRNA genes has long been simplified as ‘constitutive,’ some observations have 339
indicated that many tRNA genes are expressed in a tissue-specific fashion in diverse organisms [58,59]. Although 340
others have found the majority of isodecoders are transcribed in different cell types [28]. Several transcription 341
factors acting via TFIIIB [83] have a negative (the tumour suppressors p53 [84] and Rb [85]) or positive (the 342
proto-oncogene c-Myc) influence [83]. Regulatory sequence in the flanking or the internal regions of tRNA genes 343
do not explain tRNA expression variation [86]. Whilst DNAm is able to repress the expression of tRNA genes 344
[32], the broader chromatin environment also affects tRNA transcription. Due to the co-ordinated nature of 345
epigenomic modifications, it may also be revealing to evaluate ageing-related histone modification in these tRNA 346
loci. Furthermore, recent data from Gerber et al [87] indicates Pol-II may also have a dynamic regulatory role in 347
tRNA expression. 348
Changes in the epigenetic state of specific tRNA could be modulating transcription efficiency or even codon 349
availability in the ageing cell. tRNA gene dosage is quite closely matched to amino acid usage frequency in the 350
human exome. However, the transcriptome codon usage frequency and tRNA gene expression have been claimed 351
to vary with the replicative state of cells, separating differentiated from replicating cells [88]. Others have argued 352
that these differences are substantially explained by variation in GC content [89] and that codon usage 353
frequencies are observed to be mostly invariant in the transcriptomes of a wide range of tissues, as well as across 354
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developmental time [86]. Although, experimental stress-related states have revealed changes with an 355
over-representation of codons that are translated by rare tRNAs [90]. 356
tRNA sequences themselves are under strong structural (both secondary and tertiary) [72] as well as 357
functional constraint, which leads to an order of magnitude reduction in variation compared the background 358
genomic mutation rate [28]. Despite strong purifying selection maintaining very low variation in tRNA gene 359
bodies, tRNA genes are subject to high levels of transcription-associated mutagenesis (TAM) leading to elevated 360
mutation rates over evolutionary time in their immediate flanking sequences [91]. The possible effects of genetic 361
variation on DNA methylation mean that polymorphic tRNA could be another potential caveat to our work. 362
Although, there is no significant population variation in, for example, tRNA iMet sequences in 1,000 Genomes 363
data. Indeed, there are only 11 new isodecoder sequences with high confidence (tRNAscan scores ≥ 50) at >1% 364
population frequency [28]. There is also some evidence for tRNA copy number variation at specific loci, although 365
this remains under-characterised [92,93]. Another potential cause we considered was whether age-related somatic 366
copy number increases could be occurring in these loci. Population or somatic copy number expansions could 367
lead to increased methylated reads in MeDIP-seq without any epigenetic state change. However, this would not 368
be consistent with the targeted and array BiS conversion methodologies, where the proportion of methylated to 369
unmethylated reads would still be constant. 370
It is worth noting the parallels with known cancer and ageing epigenetic changes, and that tRNAs are also 371
dysregulated in cancer [94], with proposed utility as prognostic markers [95]. Furthermore, the early replicating 372
state of tRNA loci, potentially associated with high expression [96], may make them prone to hypermethylate, as 373
is observed in early replicating loci in both cancer [97] and senescent cells [98]. Interestingly, tRNA gene loci may 374
also play a role in local as well as large scale genome organisation [43,99]. tRNA gene clusters act as insulators 375
[100] and have extensive long-range chromatin interactions with other tRNA gene loci [43]. The coordinated 376
transcription of tRNAs at subnuclear foci and the B-box sequence elements bound by TFIIIC and not PolIII may 377
represent an organising principle for 3D-chromatin by providing spatial constraints [101]. Therefore, these tRNA 378
epigenetic changes could contribute to the structural changes that are also observed in ageing [102]. 379
In conclusion, due to the unique challenges that make the tRNA genes difficult to examine it has remained 380
epigenetically under-characterised despite its critical importance for cell function. We directly interrogated the 381
epigenetic DNA methylation state of the functionally important tRNA genes, across the age spectrum in a range 382
of datasets as well as methodologies and identified an enrichment for age-related DNA hypermethylation in the 383
human tRNA genes. 384
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Methods 385
Participants 386
Participants in the ‘EpiTwins’ study are adult volunteers from the TwinsUK Register. The participants were 387
aged between 16 and 82 years, with a median of ˜55 years (cohort profile [103]). Ethics for the collection of these 388
data were approved by Guy’s & St Thomas’ NHS Foundation Trust Ethics Committee (EC04/015—15-Mar-04) 389
and written informed consent was obtained from all participants. 390
Participants for our targeted bisulfite sequencing of select tRNA loci were drawn from two studies. Samples 391
from participants aged 4 and 28 years are from the MAVIDOS [104] study and participants aged 63 and 78 years 392
are from the Hertfordshire cohort study [105]. Due to a limited number of available samples, the two 4 year old 393
pools contained DNA from 20 individuals each, with all other pools having 25 contributing individuals. Pool 1, 394
the first 4 year old pool used DNA from all male samples, with all other pools using all female samples. Thus, 395
the total number of participants was 190 (see Table 1). Samples from the 28 year old time point are all from 396
pregnant women at ˜11 weeks gestation. 397
tRNA annotation information 398
Genomic coordinates of the tRNA genes were downloaded from GtRNAdb [27]. The 2 tRNAs located in 399
chr1 gl000192 random are tRNA-Gly-CCC-8-1 & tRNA-Asn-ATT-1-2 (Supplementary Data 6). The 213 probes 400
overlapping tRNA genes were derived from intersecting the tRNA gene annotation data from gtRNAdb with the 401
Illumina 450k array manifest annotation for the hg19 genome build using bedtools v2.17.0 [106]. We excluded 402
107 tRNAs from blacklisted regions of hg19 [46]. 403
tRNA Gene Clustering 404
We clustered the tRNA genes by grouping together all tRNAs within 5Mb of one another using the bedtools 405
merge tool v2.17.0 [106]. We used a command of the form: bedtools merge -c 4 -o collapse -d N -i 406
hg19-tRNAs.bed where N is the binsize. We varied the binsize and selected 5Mb as it is at approximately this 407
size that number of clusters with more than one tRNAs exceeds the number of singleton tRNAs (Figure 408
Supplementary Figure 9). We added the further requirements that these groupings contain at least 5 tRNA genes 409
with a density of at least 5 tRNA genes per Mb to be considered as clusters. 410
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DNA methylome data 411
TwinsUK MeDIP-seq methylomes 412
The Methylated DNA Immunoprecipitation sequencing (MeDIP-seq) data was processed as previously described 413
[16,107]. These processed data are available from the European Genome-phenome Archive (EGA) 414
(https://www.ebi.ac.uk/ega) under study number EGAS00001001910 and dataset EGAD00010000983. The 415
dataset used in this work consists of 4350 whole blood methylomes with age data. 4054 are female and 270 male. 416
3001 have full blood counts. There are 3652 individuals in this data set. These individuals originate from 1933 417
unique families. There are 1234 monozygotic (MZ) twin pairs (2468 individuals), and 458 dizygotic (DZ) twin 418
pairs (916 individuals). 419
MeDIP-seq used a monoclonal anti-5mC antibody to bind denatured fragmented genomic DNA at methylated 420
CpG sites. The kit used was the ‘MagMeDIP’ kit (Kit Cat. No.: CO2010021 mc-magme-048 from Diagenode 421
(Liège, Belgium) https://www.diagenode.com/en/p/magmedip-kit-x48-48-rxns), and the monoclonal antibody 422
was antibody 33D3 (C15200081 423
https://www.diagenode.com/en/p/5-mc-monoclonal-antibody-33d3-premium-100-ug-50-ul). The antibody was 424
incubated with Adaptor-ligated DNA combining 0.5µl antibody + 0.5µl water; then 0.6µl MagBuffer A, 1.4µl 425
water and, 2µl MagBuffer C; yielding a final volume of 5µl for the immunoprecipitation reaction. Validation 426
information including for the use of this antibody in MeDIP is provided on the manufacturer’s website in the 427
datasheet for this antibody ( 428
https://www.diagenode.com/files/products/antibodies/Datasheet 5-mC33D3 C15200081-100.pdf) This 429
antibody-bound fraction of DNA was isolated and sequenced [44]. MeDIP-seq 50-bp single-end sequencing reads 430
were aligned to the hg19/GRCh37 assembly of the human genome and duplicates were removed. MEDIPS (v1.0) 431
was used for the MeDIP-seq specific analysis [108]. This produced reads per million base pairs (RPM) values 432
binned into 500bp windows with a 250bp slide in the BED format, resulting in ˜12.8 million windows on the 433
genome. Thus all individual tRNA genes are covered by 2-3 windows. tRNAs were considered significant if any 434
window overlapping them showed significant changes. MeDIP-seq data from regions of interest was extracted 435
using Bedtools v2.17.0 [106]. 436
Analysis of DNA methylome data for Significant Ageing-related changes 437
All analysis was performed in R/3.5.2. Linear models were fitted to age using the MeDIP-seq DNA methylome 438
data, as quantile normalised RPM scores at each 500bp window. Models were fitted with: 1. No covariates; 2. 439
Batch information as a fixed effect; 3. Blood cell-type counts for neutrophils, monocytes, eosinophils, and 440
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lymphocytes as fixed effects; and 4. Batch and Blood Cell counts as fixed effects. Model 1 & 2 were fitted on the 441
full set of 4350 as batch information was available for all samples but blood cell count data was only available for 442
a subset of 3001 methylomes. Models 1 & 2 fitted in the n=3001 subset were similar to those fitted in the 443
complete set of 4350. Models 3 & 4 were fitted in the n=3001 subset with full covariate information and sets of 444
significant tRNAs identified at study-wide and genome wide levels in model 4 were used in subsequent analyses. 445
Models were also fitted for two unrelated subsets created by selecting one twin from each pair (Monozygotic or 446
Dizygotic), yeilding sets with n = 1198 & 1206 DNA methylomes. An additional model was fitted for 447
longitudinal analysis, samples were selected by identifying individuals with a DNA methylome at more than one 448
time point and filtering for only those with a minimum of 5 years between samples. This yielded 658 methylomes 449
from 329 individuals with age differences of 5-16.1 yrs, median 7.6 yrs. Models for this set included participant 450
identifier as a fixed effect in addition to blood cell counts and batch information. A mixed effects model was also 451
fit to include the effect of family structure and zygosity (n = 2989). The null model included batch, lymphocyte, 452
monocyte, neutrophil and eosinophil cell count data, as fixed effects, and family id and zygosity as random 453
effects, and was compared to the same model with the addition of the quantile normalised methylation score 454
using anova, mixed models were fit with lme4 v1.1.21 455
Permutation Analysis for Enrichment with Age-related Changes 456
We performed a permutation analysis to determine whether the CpG distribution of sets of the tRNA genes was 457
the principle driver of the ageing-related changes observed. Windows overlapping tRNAs have a higher 458
proportion of windows with a greater CpG density than their surrounding sequences (see supplementary Figure 459
Supplementary Figure 8). CpGs residing within moderate CpG density loci are the most dynamic in the genome 460
[48] and CpG dense CpG island regions include specific ageing-related changes [8,9,16]. For comparison we also 461
performed the permutation in the CGI regions from the Polycomb group protein target promoters in 462
Teschendorff et al. [8] and bivalent loci from ENCODE ChromHmm ‘Poised Promoter’ classification in the 463
GM12878 cell-line [54]. A random set of 500bp windows representing an equivalent CpG density distribution of 464
the feature set in question were selected from the genome-wide data. The number of windows selected in each 465
permutation for these features was; for tRNAs 1,320, for bivalent chromatin 42,841 and for polycomb group 466
protein target promoters 13,502. Above a certain CpG density there are insufficient windows to sample without 467
replacement within a permutation. Furthermore, above ˜≥ 18% CpG density CpG Islands become consistently 468
hypomethylated [109]. Therefore, all windows with a CpG density of ≥ 18% (45 CpGs per 500bp) were grouped 469
and sampled from the same pool. i.e. a window overlapping a tRNA gene which had a 20% density could be 470
represented in permutation by one with any density ≥ 18%. This permutation was performed 1,000 times to 471
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determine an Empirical p value by calculating the number of times the permutation result exceeded the observed 472
number of significant windows in the feature set. Empirical p− value = r+1N+1 , where r is the sum of significant 473
windows in all permutations and N is number of permutations [110]. 474
Neonate and Centenarian Whole Genome Bisulfite Sequencing 475
DNA methylation calls were downloaded from GEO: GSE31263 and intersected with tRNA genes using bedtools 476
v2.17.0 [106]. 477
Sample pooling and EPIC array 478
We performed an Illumina Infinium DNA methylation EPIC array ((C) Illumina) and targeted bisulfite 479
sequencing of select tRNA gene loci. Here we used DNA extracted from whole blood and pooled into 8 samples 480
from unrelated individuals at 4 time-points with 2 pools at each time-point. The timepoints were 4, 28, 63, and 481
78 years. Using the EPIC array we were able to infer the DNAm age using the Horvath DNAm clock [11] and 482
blood cell-type composition of our samples using the Houseman algorithm [51], as implemented in the meffil 483
v1.1.1 R package using the ’blood gse35069’ cell type reference option [111]. 484
Targeted Bisulfite Sequencing 485
We selected tRNA loci for targeted sequencing in which have had observed changes and DNAm with age and 486
closely related tRNAs in which changes were not observed. Primer design was performed using ‘methPrimer’ v1 487
[112] (Supplementary Data 7). A total of 84 tRNA loci were targeted and 79 subsequently generated reliable 488
results post-QC. The targeted tRNAs covered a total of 723 CpGs with a median of 8 CpGs per tRNA (range 489
1-13), data passing QC was generated for 458 CpGs, median 6 (range 1-9) per tRNA. 490
Quality was assessed before and after read trimming using fastqc v0.11.5 [113] and multiqc v1.0 [114] to 491
visualise the results. Targeting primers were trimmed with cutadapt v1.13 [115] and a custom perl5 script. 492
Quality trimming was performed with trim galore 0.5.0 [115]. Alignment and methylation calling was 493
performed with Bismark v0.20.0 [117] making use of bowtie2 v2.3.1 [118]. The alignment was performed against 494
both the whole hg19 genome and just the tRNA genes +/- 100bp to assess the possible impact of off-target 495
mapping. Mapping to the whole genome did produce purported methylation calls at a larger number of loci than 496
mapping just to the tRNA genes (683,783 vs 45,861 respectively). Introducing a minimum coverage threshold of 497
25 reads dramatically reduced this and brought the number of sites into line with that in the tRNA gene set 498
(36,065 vs 33,664 respectively) suggesting a small number of ambiguously mapping reads. All subsequent analysis 499
was performed using the alignment to just the tRNA genes with a minimum coverage of 25 reads. 500
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We performed pairwise differential methylation analysis of the tRNA genes at the different time points using 501
RnBeads v2.0.1 [52] with limma v3.38.3 [119] and a minimum coverage of 25 reads. We also performed linear 502
regression predicting age from DNA methylation at the targeted tRNA sites, permitting us to compare rates of 503
increase with age. For the linear regression, we used only CpG sites with more than 25 reads mapped to the 504
regions of the genome targeted for amplification. 505
TwinsUK Illumina 450k array methylomes 506
Illumina Infinium DNA methylation 450k arrays ((C) Illumina) were also performed on TwinsUK participants, in 507
770 Blood-derived DNA samples which had matched MeDIP-seq data. These data were preprocessed in the form 508
of methylation ‘beta’ values pre-processed as previously described [16,107]. Cell-type correction was performed 509
using cell-count data and the following model: lm(age ~ beta + eosinophils + lymphocytes + monocytes 510
+ neutrophils). 511
Chromatin Segmentation Data 512
Epilogos chromatin segmentation data [53] was downloaded for the tRNA gene regions +/- 200bp from 513
https://explore.altius.org/tabix/epilogos/hg19.15.Blood_T-cell.KL.gz using the tabix v1.3.2 utility. 514
The data used was the ‘Blood & T-cell’ 15 State model based on segmentation of 14 cell-types. This data was 515
manipulated and visualised with R v3.5.2 and ggplot2 v3.2.1. 516
Isolated Blood Cell Type Specific Data 517
Data from 7 cell-type fractions from 6 Male individuals was downloaded from GSE35069 [55] using GEOquery 518
v2.51.5 [119]. Five of the 6 top age hypermethylating tRNAs are covered by this array dataset. Heatmaps were 519
created with the ComplexHeatmap v1.20.0 R package [56]. 520
Cancer and Tissue Specific Methylation Data 521
Data was downloaded from the TCGA (The Cancer Genome Atlas) via the GDC (genomic data commons) data 522
portal [121] using the GenomicDataCommons R package v1.6.0. Data from foetal tissue [61,62] was downloaded 523
from GEO (GSE72867, GSE30654). From the TCGA, we selected samples for which DNAm data was available 524
from both the primary site and normal solid tissue, and for which we could infer an approximate age (within one 525
year). We selected those probes overlapping tRNA genes yielding 73,403 data points across 19 tissues with an age 526
range of 15-90yrs (median 63.4) (Supplementary Data 8) 527
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Mouse RRBS Analysis 528
We downloaded methylation calls and coverage information resulting from RRBS performed by Petkovich et al. 529
[63] from GEO using GEOquery v2.51.5 [119] GSE80672. These data from 152 mice covered 68 tRNA and 436 530
CpGs after QC requiring >50 reads per CpG and >10 data points per tRNA. We excluded 5 tRNAs from 531
blacklisted regions of mm10 [46]. After QC there were 58 tRNA genes and 385 CpGs. We performed simple 532
linear modeling to predict age from methylation level at each tRNA and each CpG. 533
Data Availability Statement 534
All data used in this study is publicly available under the following accession numbers. 535
Targeted Bisulfite sequencing data is deposited in the sequence read archive with the bioproject accession: 536
PRJNA635108 [https://www.ncbi.nlm.nih.gov/bioproject/PRJNA635108] 537
EPIC array data is deposited at GEO with the accession: GSE166503 538
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166503] 539
Neonate and Centenarian Whole Genome Bisulfite Sequencing DNA methylation calls: GSE31263 540
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31263]. 541
Human isolated blood cell-type specific DNA methylation array Data: GSE35069 542
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35069]. 543
Cancer and tissue specific DNA methylation array data from TCGA, see (Supplementary Data 8) for the full 544
list of samples drawn from genomic data commons. 545
Feotal tissue DNA methylation data were downloaded from: GSE72867 546
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72867], & GSE30654 547
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30654]. 548
Mouse whole blood RRBS DNA methylation data data: GSE80672 549
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80672]. 550
The MeDIP-seq data supporting the results of this article are available in the EMBL-EBI European 551
Genome-phenome Archive (EGA) under Data set Accession number EGAD00010000983 552
[https://www.ebi.ac.uk/ega/datasets/EGAD00010000983], access is subject to request and approval by their 553
Data Access Committee. 554
epilogos chromatin segmentation data is available from: 555
[https://explore.altius.org/tabix/epilogos/hg19.15.Blood T-cell.KL.gz] 556
Twins UK DNA metylation and age model summary data for non-overlapping 500bp windows is available at 557
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via UCSC Genome Browser’s track hub interface, add: http://epigenome.soton.ac.uk/TrackHub/hub.txt Tracks 558
include: mean, median and variance in RPM values across all samples in the model (n = 3001); the percentage of 559
samples with an exactly 0 RPM score in a given window (useful for spotting technical issues); the slope and 560
-log10(p-values) for batch corrected, and blood cell-type corrected age models. 561
tRNA gene annotations for the hg19 and mm10 genomes where acquired from GtRNAdb 562
[http://gtrnadb.ucsc.edu/] 563
Source data for all figures are provided with this paper. 564
Code availablity 565
Available at https://github.com/RichardJActon/tRNA_paper_code 566
https://doi.org/10.5281/zenodo.4294046 [122] 567
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Mange F, Praz V, Migliavacca E, Willis IM, Schütz F, Hernandez N. Diurnal regulation of RNA polymerase
III transcription is under the control of both the feeding–fasting response and the circadian clock. Genome
Research. 2017;27: 973–984. doi:10.1101/gr.217521.116
666
37. 667
Kennedy BK, Lamming DW. The mechanistic target of rapamycin: The grand ConducTOR of metabolism
and aging. Cell Metabolism. Elsevier Inc.; 2016;23: 990–1003. doi:10.1016/j.cmet.2016.05.009
668
38. 669
Nwanaji-Enwerem JC, Weisskopf MG, Baccarelli AA. Multi-tissue DNA methylation age: Molecular




Hansen M, Taubert S, Crawford D, Libina N, Lee S-J, Kenyon C. Lifespan extension by conditions




Filer D, Thompson MA, Takhaveev V, Dobson AJ, Kotronaki I, Green JWM, et al. RNA polymerase




March 1, 2021 36/44
Dhahbi JM, Spindler SR, Atamna H, Yamakawa A, Boffelli D, Mote P, et al. 5’ tRNA halves are present as
abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction.
BMC Genomics. 2013;14: 298. doi:10.1186/1471-2164-14-298
676
42. 677
Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of infinium
DNA methylation BeadChip probes. Nucleic Acids Research. 2016;45: gkw967. doi:10.1093/nar/gkw967
678
43. 679
Van Bortle K, Phanstiel DH, Snyder MP. Topological organization and dynamic regulation of human




Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, et al. A bayesian deconvolution strategy




Lowe TM, Chan PP. tRNAscan-SE on-line: Integrating search and context for analysis of transfer RNA
genes. Nucleic Acids Research. 2016;44: W54–W57. doi:10.1093/nar/gkw413
684
46. 685
Amemiya HM, Kundaje A, Boyle AP. The ENCODE blacklist: Identification of problematic regions of the
genome. Scientific Reports. 2019;9: 9354. doi:10.1038/s41598-019-45839-z
686
47. 687
Geiger H, Haan G de, Florian MC. The ageing haematopoietic stem cell compartment. Nature Reviews
Immunology. Nature Publishing Group; 2013;13: 376–389. doi:10.1038/nri3433
688
48. 689
Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LT-Y, Kohlbacher O, et al. Charting a dynamic DNA
methylation landscape of the human genome. Nature. 2013;500: 477–81. doi:10.1038/nature12433
690
49. 691
Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al. Aging and
environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context.
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MeDIP 450k Array Targeted BiS-seq
tRNA Window Slope p-value Slope p-value Slope p-value
tRNA-Gln-CTG-7-1 Chr1:147,800,750-147,801,250 0.84 2.60e-05 NA NA NA NA
Chr2:131,094,500-131,095,000 1.11 4.64e-09 NA NA NA NA
Chr2:131,094,250-131,094,750 1.00 1.12e-07 NA NA NA NAtRNA-Glu-TTC-1-1
Chr2:131,094,750-131,095,250 1.00 3.28e-07 NA NA NA NA
tRNA-His-GTG-1-2 Chr1:146,544,500-146,545,000 0.92 1.38e-06 NA NA NA NA
Chr1:149,155,750-149,156,250 1.05 2.98e-08 NA NA NA NAtRNA-His-GTG-2-1 Chr1:149,155,500-149,156,000 0.83 1.37e-05 NA NA NA NA
Chr6: 27,251,500- 27,252,000 1.07 1.45e-08 NA NA 1.30 1.22e-03tRNA-Ile-AAT-10-1 Chr6: 27,251,750- 27,252,250 0.90 1.86e-06 NA NA 1.30 1.22e-03
Chr17: 8,130,000- 8,130,500 1.19 2.98e-10 0.20 8.92e-06 -0.74 6.88e-04tRNA-Ile-AAT-4-1 Chr17: 8,130,250- 8,130,750 0.77 3.99e-05 0.20 8.92e-06 -0.74 6.88e-04
tRNA-Ile-TAT-2-2 Chr6: 26,987,750- 26,988,250 0.97 7.25e-07 0.04 1.17e-02 -0.60 3.84e-01
Chr6: 26,330,500- 26,331,000 1.28 2.83e-11 0.13 6.07e-06 4.54 9.35e-04tRNA-iMet-CAT-1-4 Chr6: 26,330,250- 26,330,750 1.13 2.89e-09 0.13 6.07e-06 4.54 9.35e-04
Chr14: 21,093,250- 21,093,750 1.04 9.38e-08 NA NA 2.49 8.77e-03tRNA-Leu-TAG-2-1 Chr14: 21,093,500- 21,094,000 0.94 8.50e-07 NA NA 2.49 8.77e-03
Chr6: 26,555,500- 26,556,000 1.04 3.97e-08 NA NA NA NAtRNA-Pro-AGG-2-2 Chr6: 26,555,250- 26,555,750 1.01 9.58e-08 NA NA NA NA
tRNA-Ser-ACT-1-1 Chr6: 27,261,250- 27,261,750 0.97 3.53e-07 NA NA 0.66 1.45e-01
Chr17: 8,129,750- 8,130,250 1.21 1.16e-10 0.21 6.72e-05 0.62 4.28e-02tRNA-Ser-AGA-2-6 Chr17: 8,130,000- 8,130,500 1.19 3.03e-10 0.21 6.72e-05 0.62 4.28e-02
tRNA-Ser-TGA-2-1 Chr6: 27,513,000- 27,513,500 0.90 3.58e-06 0.87 1.38e-04 -0.25 5.74e-01
tRNA-Val-AAC-1-2 Chr5:180,590,750-180,591,250 0.91 3.28e-06 NA NA NA NA
Chr6: 27,648,500- 27,649,000 1.07 1.25e-08 0.40 9.90e-03 NA NAtRNA-Val-AAC-4-1 Chr6: 27,648,750- 27,649,250 0.95 4.31e-07 0.40 9.90e-03 NA NA
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Significance NS p < 0.05 p < 1.147e−04
